CSWYF
Price
$1.00
Change
+$0.07 (+7.53%)
Updated
Jun 3 closing price
Capitalization
519.41M
VRBCF
Price
$346.00
Change
+$22.00 (+6.79%)
Updated
May 22 closing price
Capitalization
2.61B
Interact to see
Advertisement

CSWYF vs VRBCF

Header iconCSWYF vs VRBCF Comparison
Open Charts CSWYF vs VRBCFBanner chart's image
China Shineway Pharmaceutical Group
Price$1.00
Change+$0.07 (+7.53%)
Volume$200
Capitalization519.41M
Virbac SA
Price$346.00
Change+$22.00 (+6.79%)
Volume$23
Capitalization2.61B
CSWYF vs VRBCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSWYF vs. VRBCF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSWYF is a Hold and VRBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CSWYF: $1.00 vs. VRBCF: $346.00)
Brand notoriety: CSWYF and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CSWYF: 100% vs. VRBCF: 212%
Market capitalization -- CSWYF: $519.41M vs. VRBCF: $2.61B
CSWYF [@Pharmaceuticals: Major] is valued at $519.41M. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $2.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSWYF’s FA Score shows that 2 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • CSWYF’s FA Score: 2 green, 3 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, VRBCF is a better buy in the long-term than CSWYF.

Price Growth

CSWYF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.91%. For the same industry, the average monthly price growth was +5.75%, and the average quarterly price growth was +4.68%.

Industries' Descriptions

@Pharmaceuticals: Major (+2.91% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

FUNDAMENTALS
Fundamentals
VRBCF($2.61B) has a higher market cap than CSWYF($519M). VRBCF has higher P/E ratio than CSWYF: VRBCF (29.33) vs CSWYF (9.64). VRBCF YTD gains are higher at: 1.996 vs. CSWYF (0.000). VRBCF has higher annual earnings (EBITDA): 213M vs. CSWYF (115M). CSWYF has more cash in the bank: 643M vs. VRBCF (176M). CSWYF has less debt than VRBCF: CSWYF (2.93M) vs VRBCF (148M). VRBCF has higher revenues than CSWYF: VRBCF (1.15B) vs CSWYF (457M).
CSWYFVRBCFCSWYF / VRBCF
Capitalization519M2.61B20%
EBITDA115M213M54%
Gain YTD0.0001.996-
P/E Ratio9.6429.3333%
Revenue457M1.15B40%
Total Cash643M176M365%
Total Debt2.93M148M2%
FUNDAMENTALS RATINGS
VRBCF: Fundamental Ratings
VRBCF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOWL1.420.19
+15.45%
Werewolf Therapeutics
IVT28.120.50
+1.81%
InvenTrust Properties Corp
UPS98.251.38
+1.42%
United Parcel Service
GNE22.910.22
+0.97%
GENIE ENERGY Ltd
CIEN72.72-0.33
-0.45%
Ciena Corp

CSWYF and

Correlation & Price change

A.I.dvisor tells us that CSWYF and HAWPF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSWYF and HAWPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSWYF
1D Price
Change %
CSWYF100%
N/A
HAWPF - CSWYF
27%
Poorly correlated
N/A
SNYNF - CSWYF
3%
Poorly correlated
+1.65%
MIRA - CSWYF
1%
Poorly correlated
+2.19%
SCLX - CSWYF
1%
Poorly correlated
-2.47%
LYPHF - CSWYF
1%
Poorly correlated
N/A
More

VRBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
RCDTF - VRBCF
56%
Loosely correlated
N/A
OGN - VRBCF
1%
Poorly correlated
+4.03%
MIRA - VRBCF
1%
Poorly correlated
+2.19%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
More